TrialThe oncologist2011

A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Neora Yaal-Hahoshen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.